All Stories

  1. Revisiting the Role of γδ T Cells in Anti-CMV Immune Response after Transplantation

    Article • Viruses, May 2021, MDPI AG

    Ahmed Gaballa

  2. Characterization of ascites- and tumor-infiltrating γδ T cells reveals distinct repertoires and a beneficial role in ovarian cancer

    Article • Science Translational Medicine, January 2021, American Association for the Advancement of Science

    Ahmed Gaballa

  3. Evaluating Thymic Function After Human Hematopoietic Stem Cell Transplantation in the Personalized Medicine Era

    Article • Frontiers in Immunology, July 2020, Frontiers

    Ahmed Gaballa

  4. TOX is expressed by exhausted and polyfunctional human effector memory CD8 + T cells

    Article • Science Immunology, July 2020, American Association for the Advancement of Science

    Ahmed Gaballa

  5. CD8+γδ T Cells Are More Frequent in CMV Seropositive Bone Marrow Grafts and Display Phenotype of an Adaptive Immune Response

    Article • Stem Cells International, December 2019, Hindawi Publishing Corporation

    Ahmed Gaballa

  6. Impact of γδ T cells on clinical outcome of hematopoietic stem cell transplantation: systematic review and meta-analysis

    Article • Blood Advances, November 2019, American Society of Hematology

    Ahmed Gaballa

  7. T-cell frequencies of CD8+ γδ and CD27+ γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation

    Article • British Journal of Pharmacology, February 2019, Springer Science + Business Media

    Ahmed Gaballa

  8. Graft γδ TCR Sequencing Identifies Public Clonotypes Associated with Hematopoietic Stem Cell Transplantation Efficacy in Acute Myeloid Leukemia Patients and Unravels Cytomegalovirus Impact on Repertoire Distribution

    Article • The Journal of Immunology, February 2019, The American Association of Immunologists

    Ahmed Gaballa

  9. Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, January 2019, Elsevier

    Ahmed Gaballa

  10. Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor T cells

    Article • Cytotherapy, July 2018, Elsevier

    Ahmed Gaballa

  11. Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft Composition

    Article • Biology of Blood and Marrow Transplantation, March 2018, Elsevier

    Ahmed Gaballa

  12. Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility

    Article • Stem Cells International, January 2018, Hindawi Publishing Corporation

    Ahmed Gaballa

  13. Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients

    Article • British Journal of Pharmacology, October 2017, Springer Science + Business Media

    Ahmed Gaballa

  14. Late presenting atypical severe combined immunodeficiency (SCID) associated with a novel missense mutation in DCLRE1C

    Article • Pediatric Allergy and Immunology, October 2017, Wiley

    Ahmed Gaballa

  15. Advances in umbilical cord blood cell therapy: the present and the future

    Article • Expert Opinion on Biological Therapy, April 2017, Taylor & Francis

    Ahmed Gaballa

  16. T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome

    Article • International Journal of Molecular Sciences, October 2016, MDPI AG

    Ahmed Gaballa